ABSTRACT
whose gene locus is a 16.5 Kb DNA segment which contains genes encoding the precursor of 
INTRODUCTION

36
Streptococcus salivarius is a member of the lactic acid bacteria (LAB) that forms part of the 37 normal flora of the oral cavity, throat and upper respiratory tract (23, 28, 40, 44) . It has also been 38 observed in nasopharynx and intestinal tract, and isolated from human feces (25, 35, 44) and 39 breast milk of healthy women (1, 46) . S. salivarius strains produce a number of bacteriocins, 40 most of which are lantibiotics (22, 39, (52) (53) (54) . 41 Lantibiotics are small, heat-stable, ribosomally synthesized, post-translationally modified 42 antimicrobial peptides (bacteriocins) produced by Gram-positive bacteria (3). The lantibiotics, 43 unlike other bacteriocins, are characterized by containing the thioether amino acids lanthionine 44 (Lan) and 3-methyl-lanthionine (MeLan), and the modified amino acids di-dehydroalanine (Dha) 45 and di-dehydrobutyrine (Dhb) (55). Lantibiotics are initially synthesized as inactive linear 46 prepeptides that undergo subsequent extensive modifications to be biologically active. The 47 modifications mainly involve dehydration of serine and threonine residues, forming the di-48 dehydro amino acids Dha and Dhb, respectively, that react with the nearby C-terminally located 49 cysteine residues (seen among linear lantibiotics) to form a thioether linkage which results in the 50 formation of Lan and MeLan, respectively. Finally, the modified peptide is exported and cleaved 51 from its leader in order to be active. 52 According to a very recent classification system, lantibiotics and lantipeptides (class Ia), consist A biosynthetic gene cluster that consists of genes encoding the prepeptide (LanA), one (LanM) 60 or two modification enzymes (LanB and LanC) that introduce the thioethers, an ABC transporter 61 (LanT) which exports the bacteriocin and removes the leader or which is dedicated for export 62 function only, an extracellular protease (LanP) that removes the leader, and finally a self-63 protecting system of the producer referred to as immunity proteins (LanI(H) and/or LanFE(G)) 64 are necessary for lantibiotic production (3). Many lantibiotics are regulated by a quorum sensing 65 system consisting of a response regulator (LanR) and histidine protein kinase (LanK) and a 66 peptide pheromone (induction peptide) that sometime can be the bacteriocin itself (32).
67
Lantibiotics kill mainly Gram-positive bacteria. Some (e.g., nisin and planosporicin) are also 68 active against Gram-negative bacteria (7). In general, lantibiotics kill target cells by inhibiting 
72
Bacteriocins may have potential applications in food industry to control food spoilage and food-73 borne infections (8) and in medicine as selective antimicrobials to inhibit pathogens with no or 74 little effect on the normal flora unlike classical antibiotics that have broad-spectrum activity (37).
75
Bacteriocin production is considered as a probiotic feature, and it has convincingly been shown 76 that bacteriocin-producing probiotic lactic acid bacteria can inhibit growth of Listeria infections (12, 47) . To this end, we aimed at isolation of bacteriocin-producing LAB from 81 healthy human infants. In this study, a new bacteriocin (lantibiotic) was purified from S. 82 salivarius 5M6c and characterized at biochemical and molecular level. 
MATERIALS AND METHODS
85
Isolation and identification of bacteriocin-producing strains 86 Bacteriocin-producing strains were isolated from a fecal sample of a healthy Ethiopian infant. A 87 10-fold serial dilution of the fecal sample was done in MRS broth, after which 0.1 ml from 10 or a bacteriocin, the antimicrobial activity was tested in the presence of proteinase K (20 mg/ml).
110
Bacteriocin activity was quantified by microtiter assay as described previously (20) 
Genome sequencing and draft assembly
Approximately 100 µg of total DNA from Streptococcus salivarius 5M6c was purified using 164 Qiagen genomic tip according to manufacturer's recommendations with minor modifications to 165 optimize lysis as described above.
166
Genome sequencing was performed (GATC Biotech) using a combination of Biotech) was performed using the GS FLX shot gun data, generating 107 large contigs. The GenBank accession number for contig 00059 that contains salivaricin D locus is JN564797.
206
RESULTS
Bacteriocin production
208
In an attempt to screen fecal lactic acid bacteria of healthy infants for bacteriocin production and (Fig. 2) , respectively.
263
The remaining peaks were consistent with sodium or potassium adducts of the above set of responsible for modification, immunity, export and regulation of salivaricin D (Fig. 3A) .
272
The salivaricin D locus consists of 12 bacteriocin-related putative open reading frames (ORFs) 273 and two transposase-related genes (Fig. 3A) . Each ORF is preceded by a strong ribosome (slvD) and salivaricin N (slvN) appear to be partial duplications.
301
The slvD gene consists of 171 nucleotides that encode the 57-amino acid precursor of salivaricin 302 D, which consists of a 23-amino acid leader peptide and a 34-amino acid mature peptide (Fig. 4) .
303
The leader peptide contains the conserved motif Phe-Asn-Leu-Asp, which is a characteristic 304 feature of class Ia subclass I lantibiotics (9). It differs from the leader of nisin Q by 2 amino 305 acids, and from those of nisin A, Z or F by 5 amino acid substitutions (Fig. 4) . The mature 306 peptide has significant similarity to nisin-type of lantibiotics, with 62% identity to nisin Q (57) 307 and Z (31), 59% to nisin A (6) and F (11), and 55% identity to nisin U (56). The identities lie 308 mainly in the N-terminus, while differences were found close to the C-terminus (Fig. 4) . The shows significant similarity (65% identity and 80% similarity) to nisin Q and salivaricin D 318 precursors (Fig. 4) Because of its similarity in its pre-sequence to the pro-nisins, especially to those residues 344 involved in thioether linkage formation (Fig. 4) , we predicted the structure of salivaricin D ( 
